Loading...
9 Tranquilizers Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals, Hikma Pharmaceuticals, Purdue Pharma, Teva Pharmaceutical Industries
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: AstraZeneca, Merck, Shionogi, Mallinckrodt Pharmaceuticals, Bausch Health
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Aurora Cannabis, Medical Marijuana, ConnOils, NuLeaf Naturals, Elixinol
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Cannoid, Medical Marijuana, Elixinol, NuLeaf Naturals, Aurora Cannabis
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Aurora Cannabis, Jazz Pharmaceuticals, Canopy Growth, Acreage Holdings, Tilray Brands, Inc.
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Johnson & Johnson, Jazz Pharmaceuticals, COMPASS Pathways, MindMed Inc., Cybin Inc.
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players: GlaxoSmithKline, Sanofi, AstraZeneca, Eli Lilly and Company, Pfizer
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries, Endo International, Collegium Pharmaceutical, Mallinckrodt Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East
Major Players: Eli Lilly and Company, Johnson & Johnson, Pfizer, AstraZeneca, Otsuka
Filter Reports
By Region
By Countries